New research co-authored by RTI-HS researchers and published in Patient helps bring greater understanding of patient perspectives in hematologic cancers, particularly acute myeloid leukemia. The researchers analyzed information from a targeted literature review alongside patient-...
This study assesses the incidence rates of skeletal related events from the time of castration resistance.
Mary Beth was recommended for this honor by a committee of her peers.
Can the CIRS-BRAT framework also be used for drug delivery combination products?
Valid real-world evidence depends on being able to accurately identify exposures of interest in real-world data.
As a result of these findings, a validated coding algorithm updated to ICD-10 codes to identify psychosis associated with dementia is recommended.
we conducted an antidepressant drug utilization study in five databases in Denmark, Germany, Spain and Sweden.
When using observational data, quantifying the effect of treatment strategies that are sustained over time is not straightforward
ICER's influence on pharmaceutical policy is gaining traction. Here are keys to successful collaboration for evaluations.
A recent population-based observational study highlights important real-world evidence on treatment patterns, health care burden, occurrence of adverse events, and survival outcomes after a metastatic breast cancer (MBC) diagnosis, in particular among older women with the HR+/HER2–subtype in the...
At the Alzheimer’s Association International Conference in July, UsAgainstAlzheimer’s (UsA2) released “Preparing Us for a Cure,” three research products on key areas of Alzheimer’s disease that impact the lives of patients, caregivers, and communities.
Pregnancy-related PASSs are increasingly relying on real-world data to assess potential safety issues that could not be assessed in pre-approval clinical trials.
Atopic dermatitis (AD) and chronic hand eczema (CHE)—both often simply referred to as eczema—are among the most common dermatologic diseases. These conditions cause significant patient burden related to constant, intense itching, visible skin effects, impaired ability to interact with...
At the 16th annual RTI Authors' Awards Dinner held this month, RTI Health Solutions researchers were recognized for their research publishing achievements.
Real-world evidence on adherence, persistence, switching, and dose escalation with biologics in adult IBD in the US is limited.
Josephine Mauskopf has been awarded the Marilyn Dix Smith Leadership Award by ISPOR.
Applied Health Economics for Public Health Practice and Research, has been published. Chapter 9, coauthored by Willings Botha,
Meet researcher Naoko Ronquest, Senior Director in our HE Modeling Program.
Research just published in Value in Health compares FDA and EMA labeling for evidence based on patient-reported outcomes (PROs) of new oncology treatments approved by both agencies.
Regulators and reimbursement authorities want to utilize real-world data more consistently to capture the real-world patient and clinician experience.
This paper describes study methods, challenges, and the study’s progress so far.
Research addressing concerns about the rising cost of health care in the United States
Reliance on statistical significance, and the related statistic, the P-value, is a drawback. Here are alternatives.
The RTI-HS Festive Cheer Score (FCS) is at its peak!
In 2014, a head-to-head clinical trial compared the 96-week efficacy and tolerability of three HIV multi-drug combinations commonly used as initial treatment for individuals with HIV-1 infection.